Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Share-based Compensation came in at $392000.0 in Q1 2026, up 227.69% year-on-year from $119626.2 in Q1 2025, and down 76.68% on a QoQ basis from $1.7 million in Q4 2025.
Jushi Holdings (JUSHF) Share-based Compensation (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Share-based Compensation data on file, last reported at $392000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 227.69% year-over-year to $392000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 17.27% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, down 50.14% from the prior year.
- Share-based Compensation for Q1 2026 stood at $392000.0, down from $1.7 million in the prior quarter.
- Over the last five years, Share-based Compensation for JUSHF reached as high as $7.0 million in Q1 2022 and fell as low as -$307000.0 in Q1 2025.
- Historically, Share-based Compensation has averaged $2.2 million across 5 years, with a median of $1.5 million in 2024.
- Across the five-year window, Share-based Compensation sank 120.14% in 2025 and jumped 227.69% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $6.0 million in 2022, then tumbled by 60.36% to $2.4 million in 2023, then slumped by 46.27% to $1.3 million in 2024, then surged by 32.47% to $1.7 million in 2025, then plunged by 76.68% to $392000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $392000.0 in Q1 2026, $1.7 million in Q4 2025, and $357000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Jun 30, 2025 | 374,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 347,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 2.36 Mn |
| Dec 31, 2023 | 2.36 Mn |